Merck Receives First U.S. Patent for Improved CRISPR Genome-Ed...
DARMSTADT, Germany, Feb. 20, 2019 /PRNewswire-AsiaNet/-- -- Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research-- Helps modify difficult-to-access regions of the genome, increasing genomecoverageMerck ( https://c212.net/c/link/...
Authors: LATEST ASIANET NEWS RELEASES